Followers | 8 |
Posts | 744 |
Boards Moderated | 0 |
Alias Born | 07/16/2006 |
Thursday, February 28, 2008 12:57:07 PM
I’m guessing that those inclined to short SRDX viewed the January 2008 conference call in much the same way that I did (see #msg-26232757). In particular, the conference call did not provide any reason to expect a near-term breakout in SRDX’s operating cash flow (or reported earnings). In that an overall negative sentiment characterized the market in the first two weeks in February, the increased short position does not surprise me.
In addition, if I was a short player (and I’m not), I would argue that the exit of Koch and Olseth from the insider category represents a possible acute downside should either of them decide to sell or divest a substantial portion of their SRDX stock. Koch, in particular, is known for his charitable contributions. A charity receiving a large block of SRDX stock might be inclined to diversify through market sales.
As Background:
The proxy filed December 20, 2007 listed Dale Olseth with 1406K shares (7.7% of total outstanding) and David Koch with 964K shares (5.3% of outstanding).
Short positions equal to or greater than the 5.8M reported Feb 15 were the norm prior to the Merck collaboration agreement (see http://www.nasdaq.com/aspxcontent/shortinterests.aspx? mode=&kind=shortint&timeframe=&intraday=&charttype=&splits=&earn ings=&movingaverage=&lowerstudy=&comparison=&index=&symbol=SRDX& symbol=BAC&symbol=EXP&symbol=&symbol=&symbol=&symbol=&symbol=&sy mbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&sy mbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&sy mbol=&FormType=&mkttype=&pathname=&page=short&selected=SRDX ).
Note, you will need to copy and remove the spaces at the end of each line in the above url. I added these spaces because iHub's formating would have adjusted the page width of this message to accommodate the entire url, making the rest of the message difficult to read.
My characterization of Koch as being known for his philanthropy is based upon Melrose’s description of Koch at the last annual meeting.
Recent SRDX News
- Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System • Business Wire • 10/30/2024 06:30:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/23/2024 02:43:41 PM
- Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter • Business Wire • 10/01/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 08:06:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2024 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:25:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:24:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:02:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2024 12:00:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 11:00:10 AM
- Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results • Business Wire • 07/31/2024 11:00:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 07/09/2024 05:49:02 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 07/08/2024 08:28:06 PM
- Kuehn Law Encourages, FFNW, HCP, CALB, and SRDX Investors to Contact Law Firm • PR Newswire (US) • 06/17/2024 12:08:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/10/2024 08:57:37 PM
- Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc. • Business Wire • 06/10/2024 11:00:00 AM
- Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc. • PR Newswire (US) • 05/29/2024 10:36:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/29/2024 12:04:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/29/2024 11:28:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 11:27:01 AM
- Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million • Business Wire • 05/29/2024 11:00:00 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/24/2024 08:01:05 PM
- Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance • Business Wire • 05/01/2024 11:00:00 AM
- Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1 • Business Wire • 04/19/2024 11:00:00 AM
- Surmodics to Participate in Upcoming Investor Conferences in March and April • Business Wire • 02/27/2024 01:00:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM